Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced that results from the company’s international,...

Colibri Heart Valve Receives Patent for Controlled Release of a Percutaneous Heart Valve Device and Strengthens Management Team Broomfield, CO, April 16, 2015 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held emerging medical device company, has received its 8th allowed/granted patent directed to transcatheter...

Colibri Heart Valve to Present Long-Term Results from the Company's First-in-Human Clinical Study and Exhibit at Upcoming EuroPCR Meeting BROOMFIELD, CO, May 13, 2014 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held emerging medical device company, today announced that Dr. Bernard Chevalier will present long-term findings...

Colibri Heart Valve Announces Clinical Update in the Company's Feasibility Study of the First Ready-to-Use Transcatheter Heart Valve System BROOMFIELD, CO, Feb. 3, 2014 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held emerging medical device company, has shared findings from long-term follow-up of patients enrolled in the...

Colibri Heart Valve Concludes Patient Enrollment in First-in-Human Study of Proprietary TAVI System in Dominican Republic BROOMFIELD, CO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve, LLC, a privately held medical device company, announced that patient enrollment has concluded in the first-in-human study of...